Skip to main content

Advertisement

Log in

Molecular epidemiological investigation of Marek’s disease virus from Guangxi, China

  • Original Article
  • Published:
Archives of Virology Aims and scope Submit manuscript

Abstract

The predominant field strains of Marek’s disease virus in Guangxi were clearly different from the vaccine strain CVI988/Rispens based on sequencing of the envelope glycoprotein I (gI), glycoprotein E (gE) and oncogenic meq genes. These differences may be partly responsible for the most recent outbreaks in Guangxi.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Arvin AM, Sharp M, Smith S, Koropchak CM, Diaz PS, Kinchington P, Ruyechan W, Hay J (1991) Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4 + or CD8 + phenotype. J Immunol 146:257–264

    CAS  PubMed  Google Scholar 

  2. Cui ZhZh, Wei P, Ding JB, Zhu SJ (2004) Molecular Comparative of Marek’s disease virus strains of different pathotypes for there gI, gE, pp38 and meq gene. J Shandong Agric Univ (Natural Science Edition) 35:1–5

    Google Scholar 

  3. Huang AG, Jiang YW, Bai AB, Pan BJ, Chen XN, Yao RY, Zheng RB, Feng J (1998) Evaluation of the pathogenicity of Marek’s disease virus. Chin J Vet Med 11:5–6

    Google Scholar 

  4. Markowski-Grimsrud CJ, Schat KA (2002) Cytotoxic T lymphocyte responses to Marek’s disease herpesvirus-encoded glycoproteins. Vet Immunol Immunopathol 90:133–144

    Article  CAS  PubMed  Google Scholar 

  5. Niikura M, Dodgson J, Cheng H (2006) Direct evidence of host genome acquisition by the alphaherpesvirus Marek’s disease virus. Arch Virol 151:537–549

    Article  CAS  PubMed  Google Scholar 

  6. Renz KG, Cheetham BF, Walkden-Brown SW (2008) Amino acid substitutions or insertion in the Meq proteins could affect their transactivation and transformation abilities. In: 8th International Marek’s Disease Symposium. James Cook University, Townsville, Queensland, Australia

  7. Santin ER, Shamblin CE, Prigge JT, Arumugaswami V, Dienglewicz RL, Parcells MS (2006) Examination of the effect of a naturally occurring mutation in glycoprotein L on Marek’s disease virus pathogenesis. Avian Dis 50:96–103

    Article  PubMed  Google Scholar 

  8. Schumacher D, Tischer BK, Reddy SM, Osterrieder N (2001) Glycoproteins E and I of Marek’s disease virus serotype 1 are essential for virus growth in cultured cells. J Virol 75:11307–11318

    Article  CAS  PubMed  Google Scholar 

  9. Schumacher D, Tischer BK, Teifke JP, Wink K, Osterrieder N (2002) Generation of a permanent cell line that supports efficient growth of Marek’s disease virus (MDV) by constitutive expression of MDV glycoprotein E. J Gen Virol 83:1987–1992

    CAS  PubMed  Google Scholar 

  10. Shamblin CE, Greene N, Arumugaswami V, Dienglewicz RL, Parcells MS (2004) Comparative analysis of Marek’s disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence. Vet Microbiol 102:147–167

    Google Scholar 

  11. Spatz SJ, Silva RF (2007) Sequence determination of variable regions within the genomes of gallid herpesvirus-2 pathotype. Arch Virol 152:1665–7168

    Article  CAS  PubMed  Google Scholar 

  12. Tavlarides-Hontz P, Kumar PM, Amortegui JR, Osterrieder N, Parcells MS (2009) A deletion within glycoprotein L of Marek’s disease virus (MDV) field isolates correlates with a decrease in bivalent MDV vaccine efficacy in contact-exposed chickens. Avian Dis 53:287–296

    Article  PubMed  Google Scholar 

  13. Teng LQ, Wei P, Song ZhB, Yang DL (2009) Evaluation of the pathogenicity of a field isolate of Marek’s disease virus integrated with retroviral long terminal repeat sequence. Chin J Virol 25:376–381

    Google Scholar 

  14. Wei P, Cui ZhZh (2004) The comparison of meq genes amplified from different pathotypes of Marek’s disease virus. Abstract book of the 7th International MD Symposium. St. Catherine’s college, Oxford

    Google Scholar 

  15. Wei P, Cui ZhZh, Long JX, Jin WJ, Liu YL (2002) The development of a monoclonal antibody (McAb) against MEQ protein of Marek’s disease virus (MDV) and its applications. J Guangxi Univ 27:5–9

    Google Scholar 

  16. Witter RL (1997) Increased virulence of Marek’s disease virus field isolates. Avian Dis 41:149–163

    Article  CAS  PubMed  Google Scholar 

  17. Wu P, Reed WM, Lee LF (2001) Glycoproteins H and L of Marek’s disease virus form a hetero-oligomer essential for translocation and cell surface expression. Arch Virol 146:983–992

    Article  CAS  PubMed  Google Scholar 

  18. Zuo TR, Zhao ZY, Wei P, Wei XX, Li Y, Mo ML (2007) Isolation and identification of a field isolate of Marek’s Disease Virus with acute oncogenicity. Chin J Virol 23:218–223

    CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by grants from the Nature Science Foundation of China (NFNC no. 30860206, 39860055 and 30460099 and the Research Key Program of Guangxi University (no. 2005ZD01).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ping Wei.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Teng, Lq., Wei, P., Song, Zb. et al. Molecular epidemiological investigation of Marek’s disease virus from Guangxi, China. Arch Virol 156, 203–206 (2011). https://doi.org/10.1007/s00705-010-0840-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00705-010-0840-8

Keywords

Navigation